Par Drugs & Chemicals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, reached its floor price of Rs 156.71 after a day marked by persistent selling pressure. The 5% price band limited the maximum daily loss, but the exchange floor effectively halted further decline. This scenario typifies a lower circuit event where supply overwhelms demand to the extent that no trades can occur below the floor price. The total traded volume was 63,110 shares, with a turnover of just Rs 0.10 crore, indicating that much of the selling interest remained unfulfilled. Par Drugs & Chemicals Ltd thus faced a liquidity bottleneck, with sellers unable to exit at prices below the circuit limit — how deep is the exit problem for this micro-cap and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Delivery volumes on 3 Sep 2026 rose sharply to 1.81 lakh shares, a 69.4% increase over the 5-day average delivery volume. On a lower circuit day, this surge in delivery volume signals genuine liquidation by holders rather than speculative short-selling. Sellers are completing the transfer of shares, indicating capitulation or forced exits rather than intraday trading manoeuvres. Despite the total traded volume being relatively low, the rising delivery volume confirms that the selling pressure is substantive and not merely technical. does this delivery pattern suggest that the selling has reached a climax or is further capitulation likely?

Intraday Price Action

The stock opened at Rs 168.00 and steadily declined to close at the circuit low of Rs 156.71, marking an intraday fall of approximately 6.7%. This downward arc reflects a gradual erosion of buyer interest throughout the session, culminating in the circuit lock. The absence of any significant rebound during the day underscores the persistent imbalance between supply and demand. The intraday range highlights the speed and severity of the sell-off, which extended beyond the 5% band intraday before the circuit mechanism intervened to halt further losses.

Moving Averages and Trend Context

Interestingly, Par Drugs & Chemicals Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is an unusual technical backdrop for a stock hitting its lower circuit. This divergence suggests that the current sell-off may be driven by stock-specific factors rather than a broader downtrend. However, the lower circuit event itself signals a sudden and severe imbalance in supply and demand that the moving averages have yet to reflect. does the technical profile of Par Drugs & Chemicals Ltd show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of Rs 192.83 crore, Par Drugs & Chemicals Ltd is classified as a micro-cap stock. The liquidity profile is modest, with the stock liquid enough for a trade size of approximately Rs 0.19 crore based on 2% of the 5-day average traded value. On a lower circuit day, this limited liquidity compounds the exit risk for sellers, as the circuit lock prevents trades below the floor price. Sellers with sizeable holdings face the prospect of multi-day circuit locks if demand does not materialise, creating a challenging environment for exiting positions. how significant is the liquidity exit risk for this micro-cap and what might alleviate it?

Fundamental Context

Par Drugs & Chemicals Ltd operates in the Chemicals & Petrochemicals sector, a space often sensitive to commodity price fluctuations and regulatory changes. While the company’s fundamentals are not the focus here, the micro-cap status and sector dynamics contribute to the stock’s vulnerability to liquidity shocks and sharp price moves. The current lower circuit event is more reflective of market microstructure and trading dynamics than immediate fundamental deterioration.

Conclusion: Severity and Liquidity Caveats

The 5.0% single-day loss culminating in a lower circuit lock for Par Drugs & Chemicals Ltd highlights a pronounced imbalance between supply and demand. Rising delivery volumes confirm genuine selling by holders, not speculative shorts, while the intraday price arc from Rs 168.00 to Rs 156.71 underscores the severity of the sell-off. Despite trading above all major moving averages, the stock’s micro-cap status and limited liquidity amplify exit risks, as sellers face the prospect of multi-session circuit locks if buyers remain absent. after a 5.0% single-day loss at lower circuit, is Par Drugs & Chemicals Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →